Start free trial
Markets US Stocks Health Technology Pharmaceuticals: Other

Amphastar Pharmaceuticals, Inc
AMPH NASDAQ

AMPH
Amphastar Pharmaceuticals, Inc NASDAQ
See more on the world's #1 chartsSee more on the world's #1 charts
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
See more on the world's #1 chartsSee more on the world's #1 charts
Overview
Ideas Financials Technicals

AMPH Stock Chart

Ideas

Videos only
AMPH: Bullish move ahead
AMPH
, 240
Long
AMPH: AMPH: Bullish move ahead

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use....

Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sul
AMPH
, 60
Long
AMPH: Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sul

AMPH: Amphastar Pharmaceuticals, Inc. 2021-05-03 06:00:00 Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sulfate Injection

AMPH Receives FDA Approval for Succinylcholine Chloride Injectio
AMPH
, D
Long
AMPH: AMPH Receives FDA Approval for Succinylcholine Chloride Injectio

AMPH: Amphastar Pharmaceuticals, Inc. 2020-06-09 06:00:10 Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial

Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinep
AMPH
, D
Long
AMPH: Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinep

AMPH: Amphastar Pharmaceuticals, Inc. 2020-04-27 06:00:10 Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial

AMPH Detected possible FDA approval!!!
AMPH
, D
Long
AMPH: AMPH Detected possible FDA approval!!!

AMPH: amphastar pharma 2018-05-14 06:00:06 Detected possible FDA approval

AMPH - Buying a pullback
AMPH
, D
Long
AMPH: AMPH - Buying a pullback

Little late on this one but... I like how its relatively strong against the market and what volume is suggesting...fingers crossed

Long with confirmed bullish engulfing signal from support line
AMPH
, D
Long
AMPH: Long with confirmed bullish engulfing signal from support line

Trading from the day open with target at 21.64 with stop loss at 18.03

AMPH Short-Term Short, Long-Term Long
AMPH
, D
AMPH: AMPH Short-Term Short, Long-Term Long

Neutral Swing Short from 15 to 13.80-14.00 support zone. If 13.80-14.00 support is held , take profits and long to 16.50 price target. If 13.80-14.00 support is broken , maintain/add to your short position, cover at 12.50 price target. Bullish Swing Buy at ~13 if support is held . Sell at ~16. Do your due diligence. Trade...

Shining star?
AMPH
, D
AMPH: Shining star?

Looks coiled up.

Typical Weinstein Step
AMPH
, D
Long
AMPH: Typical Weinstein Step

AMPH in Day time frame is following the weinstein steps. we are in Step 1 , time to enter for a long run until entering step3.

Technicals

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Health Technology
Industry: Pharmaceuticals: Other
Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and intranasal products. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets, and distributes Primatene Mist, enoxaparin, naloxone, phytonadione, lidocaine, and other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment manufactures and distributes recombinant human insulin and porcine insulin. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.

News